SCHEMBL4746255

SCHEMBL4746255

c1cnc2c(c1)-c1cccc3c(-c4cc5c6cccc7c6c(cc5c5ccccc45)-c4ncccc4-7)ccc-2c13

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
CTSL P07711 1/20 0.38
CTSS P25774 1/20 0.38
PTPN13 Q12923 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
CASP1 P29466 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
THRB P10828 1/20 0.37
BLM P54132 1/20 0.37
TOP2A P11388 1/20 0.36
CYP1A2 P05177 1/20 0.36
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746256 1.00 PTPRC (0.38) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4745872 0.97 ALDH1A1 (0.41) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4746407 0.97 PTPRC (0.40) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL13320385 0.95 ALDH1A1 (0.44) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL13320396 0.95 ALDH1A1 (0.44) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4746392 0.95 ALDH1A1 (0.41) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4746454 0.94 ALDH1A1 (0.40) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4746267 0.94 ALDH1A1 (0.42) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4745978 0.91 ALDH1A1 (0.47) PTPRCALDH1A1HPGDCTSLCTSS
SCHEMBL4745841 0.90 ALDH1A1 (0.44) PTPRCALDH1A1HPGDCTSLCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 PTPRC 1306/4885ALDH1A1 179/4885HPGD 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.